News | Gore Medical

GORE ANNOUNCES FIRST U.S. ENROLLMENT FOR THE GORE^® VIAFORT VASCULAR STENT ILIOFEMORAL STUDY

FIRST U.S. PATIENT ENROLLED IN GORE® VIAFORT VASCULAR STENT ILIOFEMORAL PIVOTAL STUDY

GORE ANNOUNCES FIRST U.S. ENROLLMENT FOR THE GORE^® VIAFORT VASCULAR STENT IVC STUDY

First U.S. patient enrolled in GORE® VIAFORT Vascular Stent pivotal study.

GORE INITIATES THE RELIEF CLINICAL STUDY EVALUATING PFO CLOSURE FOR MIGRAINE HEADACHE RELIEF

The Gore RELIEF study is evaluating the safety and efficacy of transcatheter closure of patent...

Gore Completes First In-human Implants of the GORE^® VIAFORT Vascular Stent

FLAGSTAFF, Ariz. (October 28, 2022) — W. L. Gore & Associates (Gore) today announced the first...

GORE ACQUIRES INNAVASC MEDICAL, INC.

Gore, a global material science company dedicated to transforming industries and improving...

GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE^® EXCLUDER^® THORACOABDOMINAL BRANCH ENDOPROSTHESIS

FLAGSTAFF, Ariz. (APRIL 12, 2022) — Gore Medical has received Breakthrough Device designation...

GORE^® CARDIOFORM SEPTAL OCCLUDER MARKS 10 YEARS OF IMPROVING LIVES

FLAGSTAFF, Ariz. (JAN. 19, 2022) — W. L. Gore & Associates (Gore) today announced that the GORE®...

FIVE-YEAR RESULTS OF THE GORE^® EXCLUDER^® ILIAC BRANCH ENDOPROSTHESIS PIVOTAL U.S. MULTICENTER STUDY CONFIRM SAFETY, EFFICACY AND DURABILITY

FLAGSTAFF, Ariz. (August 19, 2021) — W. L. Gore & Associates (Gore), today announced that...

GORE REDUCE CLINICAL STUDY FIVE-YEAR RESULTS DEMONSTRATE THAT PFO CLOSURE WITH THE GORE^® CARDIOFORM SEPTAL OCCLUDER PROVIDES SAFE LONG-TERM REDUCTION OF RECURRENT STROKE

FLAGSTAFF, Ariz. (March 11, 2021)— W. L. Gore & Associates (Gore), today announced that Gore...

W. L. GORE & ASSOCIATES ANNOUNCES ENCOURAGING SIX-MONTH RESULTS WITH ITS NOVEL BIOSYNTHETIC TISSUE VALVE

FLAGSTAFF, Ariz. (November 18, 2020) — W. L. Gore & Associates, Inc. (Gore), a global leader in...

Media Contacts

Jessica Moran
Arizona, United States
+1 480 601 4799
jmoran@wlgore.com

Henrietta Bryan
United Kingdom
+44 (0) 7867 90 6287
hbryan@wlgore.com

GORE ANNOUNCES FIRST U.S. ENROLLMENT FOR THE GORE® VIAFORT VASCULAR STENT ILIOFEMORAL STUDY

GORE ANNOUNCES FIRST U.S. ENROLLMENT FOR THE GORE® VIAFORT VASCULAR STENT IVC STUDY

GORE INITIATES THE RELIEF CLINICAL STUDY EVALUATING PFO CLOSURE FOR MIGRAINE HEADACHE RELIEF

Gore Completes First In-human Implants of the GORE® VIAFORT Vascular Stent

GORE ACQUIRES INNAVASC MEDICAL, INC.

GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS

GORE® CARDIOFORM SEPTAL OCCLUDER MARKS 10 YEARS OF IMPROVING LIVES

FIVE-YEAR RESULTS OF THE GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS PIVOTAL U.S. MULTICENTER STUDY CONFIRM SAFETY, EFFICACY AND DURABILITY

GORE REDUCE CLINICAL STUDY FIVE-YEAR RESULTS DEMONSTRATE THAT PFO CLOSURE WITH THE GORE® CARDIOFORM SEPTAL OCCLUDER PROVIDES SAFE LONG-TERM REDUCTION OF RECURRENT STROKE

W. L. GORE & ASSOCIATES ANNOUNCES ENCOURAGING SIX-MONTH RESULTS WITH ITS NOVEL BIOSYNTHETIC TISSUE VALVE

Media Contacts

GORE ANNOUNCES FIRST U.S. ENROLLMENT FOR THE GORE^® VIAFORT VASCULAR STENT ILIOFEMORAL STUDY

GORE ANNOUNCES FIRST U.S. ENROLLMENT FOR THE GORE^® VIAFORT VASCULAR STENT IVC STUDY

Gore Completes First In-human Implants of the GORE^® VIAFORT Vascular Stent

GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE^® EXCLUDER^® THORACOABDOMINAL BRANCH ENDOPROSTHESIS

GORE^® CARDIOFORM SEPTAL OCCLUDER MARKS 10 YEARS OF IMPROVING LIVES

FIVE-YEAR RESULTS OF THE GORE^® EXCLUDER^® ILIAC BRANCH ENDOPROSTHESIS PIVOTAL U.S. MULTICENTER STUDY CONFIRM SAFETY, EFFICACY AND DURABILITY

GORE REDUCE CLINICAL STUDY FIVE-YEAR RESULTS DEMONSTRATE THAT PFO CLOSURE WITH THE GORE^® CARDIOFORM SEPTAL OCCLUDER PROVIDES SAFE LONG-TERM REDUCTION OF RECURRENT STROKE